FORA Capital’s Gilead Sciences GILD Stock Holding History

FORA Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,306	Closed	-$256K	–	522
2025 Q3	$256K	Buy	+2,306	New	+$262K	0.05%	397
2025 Q2	–	Sell	-23,895	Closed	-$2.68M	–	577
2025 Q1	$2.68M	Buy	+23,895	New	+$2.47M	0.27%	120
2024 Q2	–	Sell	-21,315	Closed	-$1.56M	–	426
2024 Q1	$1.56M	Buy	+21,315	New	+$1.64M	0.13%	188
2023 Q3	–	Sell	-46,706	Closed	-$3.6M	–	512
2023 Q2	$3.6M	Buy	+46,706	New	+$3.73M	0.51%	58
2022 Q1	–	Sell	-3,728	Closed	-$271K	–	552
2021 Q4	$271K	Buy	+3,728	New	+$257K	0.11%	238
2021 Q1	–	Sell	-19,645	Closed	-$1.15M	–	889
2020 Q4	$1.15M	Buy	+19,645	New	+$1.19M	0.17%	132
2020 Q2	–	Sell	-17,777	Closed	-$1.33M	–	1059
2020 Q1	$1.33M	Sell	17,777 -22,160	-55%	-$1.53M	0.29%	85
2019 Q4	$2.6M	Buy	+39,937	New	+$2.6M	0.26%	90

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

FORA Capital's GILD Position: Q4 2025 in Review

FORA Capital sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 2,306 shares — an estimated $256K sold.

FORA Capital first reported a position in GILD in Q4 2019 and held it in 8 quarters. The position peaked at $3.6M in Q2 2023. 2,221 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

FORA Capital reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
FORA Capital sold 2,306 Gilead Sciences shares in Q4 2025, an estimated $256K.
FORA Capital first reported a position in Gilead Sciences in Q4 2019 and held it in 8 quarters.
FORA Capital's Gilead Sciences position peaked at $3.6M in Q2 2023.
2,221 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on FORA Capital's 13F filing for Q4 2025, filed 13 Feb 2026.